D-0742-2026 Class II Ongoing
FDA drug recall D-0742-2026 was initiated by Bionpharma Inc. on Jun 26, 2026 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 29, 2026
- Initiation Date
- Jun 26, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.
Reason for recall
Presence of Foreign Tablets/Capsules
Distribution pattern
US Nationwide.
Code information
Lot# 704C003, Exp. 12/31/2028
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0742-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026